Partner Headlines - GEVA

  1. Synageva BioPharma Submits Kanuma (Sebelipase Alfa) Application ...

    Benzinga
  2. Intercept's NASH Trial Design Irks Investors

    IBD
  3. Alexion Acquiring Synageva For $8.4 Billion

    GuruFocus
  4. Benzinga's Volume Movers

    Benzinga
  5. Benzinga's Top Downgrades

    Benzinga
  6. Alexion To Acquire Synageva

    IBD
  7. Wednesday Pre-Market Insights: GEVA, BRDR, MGI, NDLS, ZU

    GuruFocus
  8. Alexion's $8.4 Billion Synageva Buyout Spooks Street

    IBD
  9. Benzinga's M&A Chatter for Wednesday May 6, 2015

    Benzinga
  10. Stocks Fall On Yellen Comment; Tesla Firm Ahead Of Earnings

    IBD
  11. Stocks Down At Midday; Apple Flirts With Sell Signal

    IBD
  12. Alexion Buying Synageva For $230 A Share; Stock Slips

    IBD
  13. Benzinga's Volume Movers

    Benzinga
  14. Synageva Shares Soar 116% On Buyout Deal With Alexion Pharmaceuticals

    Benzinga
  15. Stocks Fade From Higher Open; Synageva Surges On Buyout News

    IBD
  16. Morning Market Losers

    Benzinga
  17. Morning Market Gainers

    Benzinga
  18. Benzinga's Top #PreMarket Losers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Wedbush Securities Sees Preparations Continuing For Expected ...

    Benzinga
  21. Synageva BioPharma Announces Dosing Of Patients Commenced With ...

    Benzinga
  22. Clear Channel Outdoor, Oasis Petroleum And Other Insiders Have ...

    Benzinga
  23. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  24. 4 More Biotech Secondaries Investors Are Watching

    Benzinga
  25. Benzinga's Volume Movers

    Benzinga
  26. 4 Biotech Secondary Offerings Traders Are Watching

    Benzinga
  27. Synageva BioPharma Completes Rolling Submission Of Biologics ...

    Benzinga
  28. Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN ...

    Benzinga
  29. Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's ...

    Benzinga
  30. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  31. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  32. Markets Surge; GM June Sales Rise 1%

    Benzinga
  33. Morning Market Losers

    Benzinga
  34. SYNAGEVA BIOPHARMA

    IBD
  35. Synageva BioPharma Reports Phase 3 Study Meets Primary Endpoint ...

    Benzinga
  36. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  37. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public ...

    Benzinga
  38. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE ...

    Benzinga
  39. Benzinga's Top Initiations

    Benzinga
  40. UPDATE: Goldman Sachs initiates on Synageva Following Positive ...

    Benzinga
  41. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on ...

    Benzinga
  42. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  43. Benzinga's Volume Movers

    Benzinga
  44. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  45. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 ...

    GuruFocus
  46. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on ...

    Benzinga
  47. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  48. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack ...

    Benzinga
  49. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  50. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  51. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  52. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises ...

    Benzinga
  53. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  54. Benzinga's Top Initiations

    Benzinga
  55. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  56. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  57. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  58. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells ...

    GuruFocus
  59. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs ...

    FoxBusiness
  60. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  61. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  62. ASML, Wolverine World Wide Included in Stocks Up on High Volume ...

    FoxBusiness
  63. Synageva BioPharma Announces $80 Million Proposed Public Offering ...

    Benzinga
  64. Four Winning Trades Based on Analyst Calls

    Benzinga
  65. CF Industries Holdings, SBA Communications Corporation Included ...

    FoxBusiness
  66. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  67. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  68. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  69. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, ...

    Benzinga
  70. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel ...

    GuruFocus
  71. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal ...

    Benzinga
Trading Center